177 related articles for article (PubMed ID: 28466817)
1. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
[TBL] [Abstract][Full Text] [Related]
2. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
4. IL-21 level in Chinese HIV infected individuals and its dynamics undergoing HAART.
Zheng L; Diallo M; Chen X; Zheng Y; He Y; Zhou H; Chen Z; Luo Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1059-64. PubMed ID: 22169719
[TBL] [Abstract][Full Text] [Related]
5. The Role of IL-27 and its Receptor in the Pathogenesis of HIV/AIDS and Anti-viral Immune Response.
Zheng YH; Xiao SL; He B; He Y; Zhou HY; Chen Z; Zheng LW; He M; Wang HY; Lin YH; Cao J
Curr HIV Res; 2017; 15(4):279-284. PubMed ID: 28521720
[TBL] [Abstract][Full Text] [Related]
6. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
[TBL] [Abstract][Full Text] [Related]
7. Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART.
Shou C; Weng N; Jin Y; Feng L; Jin C; Hoextermann S; Potthoff A; Skaletz-Rorowski A; Brockmeyer NH; Wu N
Eur J Med Res; 2011 Nov; 16(11):473-9. PubMed ID: 22027639
[TBL] [Abstract][Full Text] [Related]
8. [Cellular HIV DNA quantitative testing and its significance in Chinese AIDS patients during 48 weeks' highly-active antiretroviral treatment].
Zheng YH; Alius DM; Chen X; He Y; He B; He M; Wang HY; Xiao SL; Luo Y; Yao YH; Lin YH; Chen Z; Zhou HY
Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):708-12. PubMed ID: 23158922
[TBL] [Abstract][Full Text] [Related]
9. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.
Mehraj V; Jenabian MA; Ponte R; Lebouché B; Costiniuk C; Thomas R; Baril JG; LeBlanc R; Cox J; Tremblay C; Routy JP;
AIDS; 2016 Jun; 30(10):1617-27. PubMed ID: 27045377
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model.
Yin X; Cao H; Wei Y; Li HH
Hypertens Res; 2019 Nov; 42(11):1664-1671. PubMed ID: 31235844
[TBL] [Abstract][Full Text] [Related]
11. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
12. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.
Stone SF; Price P; Keane NM; Murray RJ; French MA
HIV Med; 2002 Jan; 3(1):21-7. PubMed ID: 12059947
[TBL] [Abstract][Full Text] [Related]
13. A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients.
He Y; Li J; Zheng Y; Luo Y; Zhou H; Yao Y; Chen X; Chen Z; He M
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):339-45. PubMed ID: 21767239
[TBL] [Abstract][Full Text] [Related]
14. Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy.
Chitra P; Bakthavatsalam B; Palvannan T
Clin Chim Acta; 2011 May; 412(11-12):1151-4. PubMed ID: 21300045
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients.
Mastroianni CM; Forcina G; d'Ettorre G; Lichtner M; Mengoni F; D'Agostino C; Vullo V
HIV Clin Trials; 2001; 2(2):108-12. PubMed ID: 11590518
[TBL] [Abstract][Full Text] [Related]
18. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
[TBL] [Abstract][Full Text] [Related]
19. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
